Sanuwave Health, Inc. (SNWV) Reports Prelim Q2 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter 2024 (Ended June 30, 2024)
July 10, 2024 7:09 AM EDTSANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history.
Q1 2024 revenue increased between 50% and 54% compared to Q2 2023.
UltraMist revenues for Q2 2024 increased by more than 60% versus Q2 2023 and accounted for approximately 97% of the Companys total revenues.
UltraMist applicator sales were an all time quarterly record and were approximately 65% of total revenues.
EDEN PRAIRIE, MN - (NewMediaWire) - July 10, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE) (OTCQB: SNWV), a leading provider of next-generation... More
